Who owns Anixa Biosciences Inc Com stock?
- Ticker: ANIX
- CUSIP Number: 03528h109
Tip: Access positions for across all investors
Analyze quarterly positions in Anixa Biosciences with up to 7 years of data, all consolidated into one spreadsheet
Download as csv Download as ExcelTop investors of Anixa Biosciences stock
Who bought or sold Anixa Biosciences Inc Com stock this quarter?
Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
---|---|---|---|---|---|
Vanguard Group | 1.4M | $4.3M | 0% | Mar 2024 |
|
Laird Norton Tyee Trust | 604k | $1.9M | 100% | Mar 2024 |
|
UBS Group | 536k | $1.7M | -8% | Mar 2024 |
|
Mission Wealth Management | 502k | $1.6M | 0% | Mar 2024 |
|
Susquehanna International | 361k | $1.1M | 385% | Mar 2024 |
|
Geode Capital Management | 320k | $999k | 7% | Mar 2024 |
|
Long Focus Capital Management | 166k | $517k | 0% | Mar 2024 |
|
BlackRock | 155k | $483k | -4% | Mar 2024 |
|
Jane Street | 122k | $380k | 181% | Mar 2024 |
|
Bank of America Corporation | 117k | $365k | 591% | Mar 2024 |
|
Qube Research & Technologies | 93k | $291k | 2333475% | Mar 2024 |
|
Bank of New York Mellon | 87k | $272k | -10% | Mar 2024 |
|
Northern Trust | 63k | $196k | 17% | Mar 2024 |
|
Citadel Advisors | 57k | $177k | 23% | Mar 2024 |
|
Cambridge Investment Research Advisors | 41k | $128k | 2% | Mar 2024 |
|
CI Private Wealth | 37k | $117k | 0% | Mar 2024 |
|
Morgan Stanley | 37k | $116k | 1% | Mar 2024 |
|
Gemmer Asset Management | 35k | $109k | 0% | Mar 2024 |
|
LPL Financial | 27k | $83k | -5% | Mar 2024 |
|
Marshall Wace | 26k | $82k | 147% | Mar 2024 |
|
Dimensional Fund Advisors | 21k | $66k | 0% | Mar 2024 |
|
Tyler-Stone Wealth Management | 21k | $66k | 0% | Mar 2024 |
|
Goldman Sachs Group | 21k | $64k | 100% | Mar 2024 |
|
Occudo Quantitative Strategies | 19k | $58k | 100% | Mar 2024 |
|
Raymond James & Associates | 18k | $55k | -68% | Mar 2024 |
|
Cubist Systematic Strategies | 17k | $52k | 100% | Mar 2024 |
|
Virtu Financial | 16k | $50k | 47% | Mar 2024 |
|
Squarepoint Ops | 16k | $50k | 100% | Mar 2024 |
|
Keybank National Association | 16k | $48k | 0% | Mar 2024 |
|
Sawtooth Asset Management | 16k | $60k | 0% | Dec 2023 |
|
Nations Financial Group | 15k | $47k | 0% | Mar 2024 |
|
Oakmont Partners | 15k | $47k | 0% | Mar 2024 |
|
International Assets Investment Management | 14k | $47k | 0% | Mar 2024 |
|
Simplicity Wealth | 14k | $44k | 100% | Mar 2024 |
|
Westside Investment Management | 14k | $43k | 0% | Mar 2024 |
|
HighTower Advisors | 14k | $42k | 0% | Mar 2024 |
|
Charles Schwab Investment Management | 13k | $40k | 0% | Mar 2024 |
|
Advisory Services Network | 11k | $35k | 81% | Mar 2024 |
|
Staley Capital Advisers | 10k | $31k | 100% | Mar 2024 |
|
Simplex Trading | 9.1k | $28k | 2989% | Mar 2024 |
|
Tower Research Capital | 5.5k | $17k | -65% | Mar 2024 |
|
Pnc Financial Services | 3.2k | $10k | 7% | Mar 2024 |
|
Citigroup | 2.1k | $6.5k | 37% | Mar 2024 |
|
Ancora Advisors | 1.5k | $4.7k | 0% | Mar 2024 |
|
Advisor Group Holdings | 1.4k | $4.4k | 250% | Mar 2024 |
|
Principal Securities | 1.0k | $3.1k | 0% | Mar 2024 |
|
Royal Bank of Canada | 1.0k | $3.0k | -13% | Mar 2024 |
|
Wells Fargo & Company | 748.00 | $2.3k | 1% | Mar 2024 |
|
Larson Financial Group | 500.00 | $1.6k | -5% | Mar 2024 |
|
Park Circle | 500.00 | $1.6k | 0% | Mar 2024 |
|
Us Bancorp | 400.00 | $1.2k | 0% | Mar 2024 |
|
FMR | 250.00 | $780.000000 | 100% | Mar 2024 |
|
Barrett & Company | 80.00 | $250.000000 | 0% | Mar 2024 |
|
Tucker Asset Management | 10.00 | $39.000000 | 0% | Dec 2023 |
|
Who sold out of Anixa Biosciences?
Fund or Company Name | Date Sold | Shares Held | Valued At |
---|---|---|---|
Bridgeway Capital Management | Sep 2023 | 21k | $69k |
Concorde Asset Management | Dec 2023 | 16k | $60k |
Jpmorgan Chase & Co | Dec 2023 | 6.9k | $27k |
Tradition Wealth Management | Dec 2023 | 5.6k | $22k |
Livelsberger Financial Advisory | Dec 2023 | 1.6k | $6.3k |
Group One Trading | Sep 2023 | 1.6k | $5.2k |